Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Gastrointestinal Neoplasms 3Esophageal Neoplasms 2Stomach Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Appendiceal Neoplasms 1

Interventions

Paclitaxel 8Hyperthermic Intraperitoneal Chemotherapy 6Mitomycin 5Cisplatin 5Fluorouracil 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Doxorubicin 3Cytoreduction Surgical Procedures 3Carboplatin 3Blood Specimen Collection 3sodium thiosulfate 2pembrolizumab 2Standard of Care 2Laparoscopy 2soluble LAG-3 protein, human 1relacorilant 1oregovomab 1olaparib 1nilotinib 1liposomal doxorubicin 1irinotecan sucrosofate 1dehydroftorafur 1avelumab 1X-Rays 1Topotecan 1Taxes 1Specimen Handling 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Neoplasms × Pafolacianine × 1 year × Clear all
NCT06511037 2026-02-27

PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

University of California, Irvine

Phase EARLY_PHASE1 Recruiting
10 enrolled
GastrointestinalGynecologic

Gastrointestinal Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡